LEGISLATIVE BUDGET BOARD

Austin, Texas

FISCAL NOTE, 80TH LEGISLATIVE REGULAR SESSION

March 11, 2007

TO:	Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services
FROM:	John S. O'Brien, Director, Legislative Budget Board
IN RE:	SB409 by Janek (Relating to restrictions on the substitution of generically equivalent versions of antiepileptic and antiseizure drugs.), As Introduced

No significant fiscal implication to the State is anticipated.

The bill requires pharmacists to dispense the specific formulation, manufactured by the specific manufacturer, prescribed by a patient's physicians when the drugs are to be used for the treatment of epilepsy or the prevention of seizures; pharmacists may substitute a generically-equivalent drug product if the pharmacist obtains a signed authorization from the prescribing physician.

Local Government Impact

No fiscal implication to units of local government is anticipated.

Source Agencies:

515 Board of Pharmacy, 537 State Health Services, Department of, 539 Aging and Disability Services, Department of

LBB Staff:

JOB, CL, PP, LR